Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study

• Main Authors: Chien-Yu Cheng (Author), Ying-Shih Su (Author), Chyi-Liang Chen (Author), Mingi Chang (Author), Shu-Wei Huang (Author), Peng-Nien Huang (Author), Shin-Ru Shih (Author), Yu-Shen Hsu (Author), Cheng-Hsun Chiu (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The objective of the study was to assess the safety, tolerability, and potential efficacy of intranasally administered AD17002, a detoxified form of Escherichia coli heat-labile enterotoxin, in treating individuals with mild-to-moderate coronavirus disease of 2019 (COVID-19). In this randomized, dou...